down arrow

PepGen Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7133171055
USD
5.20
-0.07 (-1.33%)

Dec 18

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

5.085.61

52 Week

0.886.72
Valuation
Technical
Day's Volume

CASH

515.54 k

Shareholding (Mar 2025)

FII

3.35%

Held by 30 FIIs

DII

75.91%

Held by 17 DIIs

Promoter

7.55%

How big is PepGen Inc.?

22-Jun-2025

As of Jun 18, PepGen Inc. has a market capitalization of 46.14 million, with net sales of 0.00 million and a net profit of -102.16 million over the last four quarters. The company has shareholder's funds of 118.62 million and total assets of 150.88 million as of Dec 24.

Market Cap: As of Jun 18, PepGen Inc. has a market capitalization of 46.14 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, PepGen Inc. reported net sales of 0.00 million and a net profit of -102.16 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company had shareholder's funds amounting to 118.62 million and total assets of 150.88 million.

Read More

What does PepGen Inc. do?

22-Jun-2025

PepGen Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $30 million and a market cap of $46.14 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -111.28%.

Overview:<BR>PepGen Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>- Most recent Net Profit: -30 Million (Quarterly Results - Mar 2025)<BR>- Market cap: USD 46.14 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: NA (Loss Making)<BR>- Industry P/E: NA<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -1.03<BR>- Return on Equity: -111.28%<BR>- Price to Book: 0.50<BR><BR>Contact Details:<BR>No Company Details Available.

Read More

Is PepGen Inc. technically bullish or bearish?

20-Sep-2025

As of August 29, 2025, PepGen Inc. has a mildly bearish technical trend with mixed signals across indicators, significantly underperforming the S&P 500 with year-to-date returns of -45.91% versus 12.22%.

As of 29 August 2025, the technical trend for PepGen Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The Bollinger Bands show a bullish signal on the weekly timeframe but a mildly bearish signal on the monthly. Moving averages are mildly bearish on the daily timeframe. The Dow Theory suggests a mildly bullish outlook weekly, but mildly bearish monthly. Overall, the technical stance is mildly bearish, with mixed signals across different indicators.<BR><BR>In terms of performance, PepGen has significantly underperformed compared to the S&P 500, with a year-to-date return of -45.91% versus the S&P's 12.22%, and a one-year return of -77.86% compared to the S&P's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 49 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.00

stock-summary
Return on Equity

-136.20%

stock-summary
Price to Book

0.69

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-23 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
153.66%
0%
153.66%
6 Months
253.74%
0%
253.74%
1 Year
28.08%
0%
28.08%
2 Years
-26.03%
0%
-26.03%
3 Years
-63.41%
0%
-63.41%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

PepGen Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-157.99%
EBIT to Interest (avg)
-89.41
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.03
Sales to Capital Employed (avg)
0
Tax Ratio
0.60%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.53
EV to EBIT
0.42
EV to EBITDA
0.42
EV to Capital Employed
15.94
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3821.69%
ROE (Latest)
-111.28%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 22 Schemes (13.19%)

Foreign Institutions

Held by 30 Foreign Institutions (3.35%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 18.37% vs -45.13% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-23.60",
          "val2": "-30.10",
          "chgp": "21.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-23.10",
          "val2": "-28.30",
          "chgp": "18.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -14.50% vs -13.75% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-96.20",
          "val2": "-83.60",
          "chgp": "-15.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-90.00",
          "val2": "-78.60",
          "chgp": "-14.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-23.60
-30.10
21.59%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-23.10
-28.30
18.37%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 18.37% vs -45.13% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-96.20
-83.60
-15.07%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-90.00
-78.60
-14.50%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -14.50% vs -13.75% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About PepGen Inc. stock-summary
stock-summary
PepGen Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."